Found: 84
Select item for more details and to access through your institution.
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 13, p. 4073, doi. 10.1007/s00259-024-06830-7
- By:
- Publication type:
- Article
High‐resolution and high‐sensitivity PET for quantitative molecular imaging of the monoaminergic nuclei: A GATE simulation study.
- Published in:
- Medical Physics, 2022, v. 49, n. 7, p. 4430, doi. 10.1002/mp.15653
- By:
- Publication type:
- Article
IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
- Published in:
- Molecular Human Reproduction, 2005, v. 11, n. 9, p. 631, doi. 10.1093/molehr/gah230
- By:
- Publication type:
- Article
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31668-8
- By:
- Publication type:
- Article
Malignant perivascular epithelioid cell tumor of the ileum on <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography with pathological correlation.
- Published in:
- World Journal of Nuclear Medicine, 2021, v. 20, n. 2, p. 208, doi. 10.4103/wjnm.WJNM_119_20
- By:
- Publication type:
- Article
Mucinous urachal adenocarcinoma: A potential nonfluorodeoxyglucose-avid pitfall on <sup>18</sup>fluorine-fluorodeoxyglucose positron emission tomography/computed tomography.
- Published in:
- World Journal of Nuclear Medicine, 2020, v. 19, n. 4, p. 432, doi. 10.4103/wjnm.WJNM_60_19
- By:
- Publication type:
- Article
Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 127, doi. 10.1111/bjh.19462
- By:
- Publication type:
- Article
Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites(Youwen Yang and Ji-Fan Hu contributed equally to this work.).
- Published in:
- Journal of Cellular Biochemistry, 2003, v. 90, n. 5, p. 1038, doi. 10.1002/jcb.10684
- By:
- Publication type:
- Article
An unsuspected MR projectile: A 'wooden' chair with metal bracing.
- Published in:
- Journal of Magnetic Resonance Imaging, 2006, v. 23, n. 5, p. 781, doi. 10.1002/jmri.20573
- By:
- Publication type:
- Article
Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00352-z
- By:
- Publication type:
- Article
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim–Chester Disease.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3240, doi. 10.3390/cancers12113240
- By:
- Publication type:
- Article
Musculoskeletal tumors and tumor-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer: Part A: benign conditions that may mimic malignancy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Musculoskeletal tumours and tumour-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer: Part B: malignant mimics of benign tumours.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Musculoskeletal tumors and tumor-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer.
- Published in:
- International Orthopaedics, 2013, v. 37, n. 5, p. 871, doi. 10.1007/s00264-013-1823-7
- By:
- Publication type:
- Article
Musculoskeletal tumours and tumour-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer.
- Published in:
- International Orthopaedics, 2013, v. 37, n. 5, p. 877, doi. 10.1007/s00264-013-1824-6
- By:
- Publication type:
- Article
Detection of Biochemically Recurrent Prostate Cancer with [ 18 F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters.
- Published in:
- Tomography: A Journal for Imaging Research, 2023, v. 9, n. 4, p. 1504, doi. 10.3390/tomography9040120
- By:
- Publication type:
- Article
Neurologic and oncologic features of Erdheim–Chester disease: a 30-patient series.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 7, p. 979, doi. 10.1093/neuonc/noaa008
- By:
- Publication type:
- Article
Comment on Hatzoglou et al: Dynamic contrastenhanced MRI perfusion versus <sup>18</sup>FDG PET/CT in differentiating brain tumor progression from radiation injury.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 2, p. 300, doi. 10.1093/neuonc/now268
- By:
- Publication type:
- Article
A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 6, p. 873, doi. 10.1093/neuonc/nov301
- By:
- Publication type:
- Article
F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 11, p. 1937, doi. 10.1007/s00259-016-3402-9
- By:
- Publication type:
- Article
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 11, p. 1666, doi. 10.1007/s00259-015-3080-z
- By:
- Publication type:
- Article
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 11, p. e1916211, doi. 10.1001/jamanetworkopen.2019.16211
- By:
- Publication type:
- Article
Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 5, p. 644, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V
- By:
- Publication type:
- Article
Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.
- Published in:
- International Journal of Cancer, 2000, v. 85, n. 3, p. 330, doi. 10.1002/(SICI)1097-0215(20000201)85:3<330::AID-IJC6>3.0.CO;2-U
- By:
- Publication type:
- Article
Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e19, doi. 10.1016/j.clml.2019.09.027
- By:
- Publication type:
- Article
Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Interreader and Intrareader Reproducibility of <sup>18</sup>F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267306
- By:
- Publication type:
- Article
<sup>61</sup>Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267126
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 386, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-<sup>18</sup>F-Fluoro-17β-Fluoroestradiol.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 351, doi. 10.2967/jnumed.123.265420
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 1, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 32, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article